1 week ARS Pharma Jumps After Inking $145 Million Deal For Epinephrine Nasal SprayInvestor's Business Daily X
1 week Corbus Pharmaceuticals’ Sell-Off: Speculative Entry Price In Oncology And Obesity TherapiesSeeking Alpha X
2 weeks 1 Growing Biotech Stock to Buy Today With $1,000 and Hold for 5 Years or MoreThe Motley Fool X
2 weeks Wall Street Analysts Think ARS Pharmaceuticals, Inc. (SPRY) Could Surge 67.56%: Read This Before Placing a BetZacks X
2 weeks Vertex Pharmaceuticals: Strong Execution Continued In Q3 But The Valuation Reflects ItSeeking Alpha X
2 weeks Earnings call: Supernus Pharmaceuticals reported a significant increase in total revenueInvesting.com X
2 weeks Vertex Pharmaceuticals Incorporated 2024 Q3 – Results – Earnings Call PresentationSeeking Alpha X
Market Insider